Bristol-Myers Squibb
BMY
BMY
2,237 hedge funds and large institutions have $77.9B invested in Bristol-Myers Squibb in 2024 Q3 according to their latest regulatory filings, with 266 funds opening new positions, 810 increasing their positions, 918 reducing their positions, and 131 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,237
Holders Change
+109
Holders Change %
+5.12%
% of All Funds
32.35%
Holding in Top 10
26
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+44.44%
% of All Funds
0.38%
New
266
Increased
810
Reduced
918
Closed
131
Calls
$1.88B
Puts
$1.99B
Net Calls
-$110M
Net Calls Change
+$34.9M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$365M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$256M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$221M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$206M |
| 5 |
Millennium Management
New York
|
+$191M |
